Javascript must be enabled to continue!
Investigation of the interplay between SKP2, CDT1 and Geminin in cancer cells
View through CrossRef
Geminin has a dual role in the regulation of DNA replication: it inhibits replication factor CDT1 activity during the G2 phase of the cell cycle and promotes its accumulation at the G2/M transition. In this way Geminin prevents DNA re-replication during G2 phase and ensures that DNA replication is efficiently executed in the next S phase. CDT1 was shown to associate with SKP2, the substrate recognition factor of the SCF ubiquitin ligase complex. We investigated the interplay between these three proteins in cancer cell lines. We show that Geminin, CDT1 and SKP2 could possibly form a complex and propose the putative regions of CDT1 and Geminin involved in the binding. We also show that, despite the physical interaction, SKP2 depletion does not substantially affect CDT1 and Geminin protein levels. Moreover, we show that while Geminin and CDT1 levels fluctuate, SKP2 levels, differently than in normal cells, are almost steady during the cell cycle of the tested cancer cells.
Title: Investigation of the interplay between SKP2, CDT1 and Geminin in cancer cells
Description:
Geminin has a dual role in the regulation of DNA replication: it inhibits replication factor CDT1 activity during the G2 phase of the cell cycle and promotes its accumulation at the G2/M transition.
In this way Geminin prevents DNA re-replication during G2 phase and ensures that DNA replication is efficiently executed in the next S phase.
CDT1 was shown to associate with SKP2, the substrate recognition factor of the SCF ubiquitin ligase complex.
We investigated the interplay between these three proteins in cancer cell lines.
We show that Geminin, CDT1 and SKP2 could possibly form a complex and propose the putative regions of CDT1 and Geminin involved in the binding.
We also show that, despite the physical interaction, SKP2 depletion does not substantially affect CDT1 and Geminin protein levels.
Moreover, we show that while Geminin and CDT1 levels fluctuate, SKP2 levels, differently than in normal cells, are almost steady during the cell cycle of the tested cancer cells.
Related Results
GW24-e2279 Geminin interference facilitate vascular smooth muscle cells proliferation via up-regulation of Cdt1
GW24-e2279 Geminin interference facilitate vascular smooth muscle cells proliferation via up-regulation of Cdt1
Objectives
Silencing Geminin gene selectively by using RNA interference and investigate the mechanism of the Geminin gene silence regulating VSMCs proliferation.
...
GW24-e0646 The effects of RNA interference targeting geminin gene on the proliferation of vascular smooth muscle cells in rats
GW24-e0646 The effects of RNA interference targeting geminin gene on the proliferation of vascular smooth muscle cells in rats
Objectives
To investigate the effects of geminin gene on the proliferation and phenotype of VSMCs in rats by using the siRNA method, and analyse the mechanism of ...
High Skp2/Low p57
Kip2
Expression is Associated with Poor Prognosis in Human Breast Carcinoma
High Skp2/Low p57
Kip2
Expression is Associated with Poor Prognosis in Human Breast Carcinoma
Downregulation of p57
Kip2
is involved in tumor progression, and S-phase kinase-associated protein 2 (Skp2) is an E3 ligase that regulates a...
Lysophosphatidic Acid-induced EGFR Transactivation Promotes Gastric Cancer DNA Replication Through Up-Regulation of Geminin
Lysophosphatidic Acid-induced EGFR Transactivation Promotes Gastric Cancer DNA Replication Through Up-Regulation of Geminin
Abstract
BackgroundLysophosphatidic acid (LPA) is one of the simplest active phospholipid molecules. Binding to its receptors on the cell surface, LPA initiates various int...
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
Abstract
Purpose: Skp2 is a subunit of the SCF ubiquitin protein ligase, which plays a vital role in the control of tumorigenesis via its regulation of G1-S transiti...
Abstract 1805: LSD1 regulation of SKP2 expression in prostate cancer.
Abstract 1805: LSD1 regulation of SKP2 expression in prostate cancer.
Abstract
Prostate carcinogenesis is a complicated process involving both genetic and epigenetic changes. Aberrant expression of LSD1 (Lysine-specific demethylase 1) ...
The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells
The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells
Abstract
Introduction
Loss of the cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in breast cancer. The decr...
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has rema...

